(Q34077942)

30 July 2017

1 reference

title

Is hypercholesterolemia a risk factor and should it be treated in the elderly? (English)

1 reference

30 July 2017

0 references

0 references

Hall KM

1

1 reference

30 July 2017

Luepker RV

series ordinal

2

1 reference

30 July 2017

language of work or name

1 reference

1 July 2000

1 reference

American Journal of Health Promotion

30 July 2017

published in

1 reference

30 July 2017

volume

14

1 reference

30 July 2017

issue

6

1 reference

30 July 2017

page(s)

347-356

1 reference

Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT).

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.4278%2F0890-1171-14.6.347

Epidemiology of coronary heart disease: the Framingham study.

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2F0890-1171-14.6.347

Serum cholesterol as a prognostic factor after myocardial infarction: the Framingham Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2F0890-1171-14.6.347

Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2F0890-1171-14.6.347

Mechanistic studies of high-density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2F0890-1171-14.6.347

Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2F0890-1171-14.6.347

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2F0890-1171-14.6.347

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2F0890-1171-14.6.347

Time Trends in the Use of Cholesterol-Lowering Agents in Older Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2F0890-1171-14.6.347

Cholesterol, diastolic blood pressure, and stroke: 13 000 strokes in 450 000 people in 45 prospective cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2F0890-1171-14.6.347

Ischemic heart disease risk factors after age 50.

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2F0890-1171-14.6.347

Total Serum Cholesterol Levels and Mortality Risk as a Function of Age

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2F0890-1171-14.6.347

Serum lipids and incidence of coronary heart disease. Findings from the Systolic Hypertension in the Elderly Program (SHEP).

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2F0890-1171-14.6.347

Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2F0890-1171-14.6.347

41-month follow-up of risk factors correlated with new coronary events in 708 elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2F0890-1171-14.6.347

Is elevated serum cholesterol level a risk factor for coronary heart disease in the elderly?

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2F0890-1171-14.6.347

Systematic underestimation of association between serum cholesterol concentration and ischaemic heart disease in observational studies: data from the BUPA study

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2F0890-1171-14.6.347

Is the serum cholesterol-coronary heart disease relationship modified by activity level in older persons?

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2F0890-1171-14.6.347

How to read a paper. The Medline database

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2F0890-1171-14.6.347

Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2F0890-1171-14.6.347

The value of lowering cholesterol after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2F0890-1171-14.6.347

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2F0890-1171-14.6.347

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2F0890-1171-14.6.347

Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2F0890-1171-14.6.347

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2F0890-1171-14.6.347

Stroke, statins, and cholesterol. A meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2F0890-1171-14.6.347

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2F0890-1171-14.6.347

MRC/BHF Heart Protection Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2F0890-1171-14.6.347

Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2F0890-1171-14.6.347

Design of the Women’s Health Initiative Clinical Trial and Observational Study

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2F0890-1171-14.6.347

Screening for coronary heart disease in elderly men based on current and past cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2F0890-1171-14.6.347

To what extent do cardiovascular risk factor values measured in elderly men represent their midlife values measured 25 years earlier? A preliminary report and commentary from the Honolulu Heart Program.

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2F0890-1171-14.6.347

The relative influence of secondary versus primary prevention using the National Cholesterol Education Program Adult Treatment Panel II guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2F0890-1171-14.6.347

Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2F0890-1171-14.6.347

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2F0890-1171-14.6.347

Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2F0890-1171-14.6.347

The design of a prospective study of pravastatin in the elderly at risk (PROSPER)

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2F0890-1171-14.6.347

10.4278/0890-1171-14.6.347

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference